DMAQ
Closed
Deep Medicine Acquisition Corp
2.98
+0.02 (+0.68%)
Last Update: 01 Feb 2024 03:59:00
Yesterday: 2.96
Day's Range: 0. - 0.
Send
sign up or login to leave a comment!
When Written:
10.62
Deep Medicine Acquisition Corp is a special purpose acquisition company (SPAC) that was formed in 2021. The company was created with the purpose of acquiring and merging with a healthcare technology or services company. The company is led by CEO and Chairman Glen de Vries, who is also the co-founder of Medidata Solutions, a cloud-based platform for clinical research.
The company raised $100 million in its initial public offering (IPO) in February 2021. The funds raised will be used to acquire a healthcare company that is focused on using artificial intelligence and machine learning to improve patient outcomes.
Deep Medicine Acquisition Corp is listed on the NASDAQ stock exchange under the ticker symbol "DMDA".
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
The company raised $100 million in its initial public offering (IPO) in February 2021. The funds raised will be used to acquire a healthcare company that is focused on using artificial intelligence and machine learning to improve patient outcomes.
Deep Medicine Acquisition Corp is listed on the NASDAQ stock exchange under the ticker symbol "DMDA".
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!